Amorphous strontium polyphosphate microparticles for treatment of osteoporosis and inducing bone cell mineralization
GB201701403D0
Formulation based on polyphosphate microparticles for topical treatment of difficult-to-heal wounds
GB201612280D0
Amorphous hyaluronic acid magnesium/calcium polyphosphate microparticles for cartilage regeneration and repair
US2017319740A1
Bioactive Wound Dressing and Teeth Coating Based on Morphogenetically Active Amorphous Calcium Polyphosphate
CN106999630A
It is used as the coated layer with morphogenic activity and the amorphous inorganic polyphosphate calcium phosphate and calcium carbonate granule of support
EP3220967A1
Morphogenetically active amorphous calcium polyphosphate nanoparticles for therapeutic applications
EP2716722A1
Synergistically acting polyphosphate- bisphosphonate-copper combinations for antifouling paints
EP2489346A1
Food supplement and injectable material for prophylaxis and therapy of osteoporosis and other bone diseases
EP2409710A1
Injectable material and material to be used as drug or food supplement for prophylaxis or treatment of osteoporosis
DE102009024603A1
Preparing bioactive, dental hard tissue sealed toothpaste comprises enzyme-catalyzed formation of nanoparticles comprising amorphous silicon dioxide using a polypeptide comprising animal, bacterial, plant or fungal silicatein domains
CN101506365A
Biosilica-adhesive protein nanocomposite materials: synthesis and application in dentistry
DE10352433A1
Polypeptide of a silicatein-ß from Suberites domuncula, nucleic acid coding therefor, their uses, vector comprising this nucleic acid and host cell expressing this polypeptide
